- Home
- ZVIA vs NVCT Comparison
ZVIA vs NVCT Comparison
Compare ZVIA & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVIA
- NVCT
- Stock Information
- Founded
- ZVIA 2007
- NVCT 2020
- Country
- ZVIA United States
- NVCT United States
- Employees
- ZVIA N/A
- NVCT N/A
- Industry
- ZVIA Beverages (Production/Distribution)
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- ZVIA Consumer Staples
- NVCT Health Care
- Exchange
- ZVIA Nasdaq
- NVCT Nasdaq
- Market Cap
- ZVIA 116.8M
- NVCT 119.4M
- IPO Year
- ZVIA 2021
- NVCT 2022
- Fundamental
- Price
- ZVIA $2.19
- NVCT $5.10
- Analyst Decision
- ZVIA Hold
- NVCT Strong Buy
- Analyst Count
- ZVIA 4
- NVCT 1
- Target Price
- ZVIA $1.56
- NVCT $21.00
- AVG Volume (30 Days)
- ZVIA 721.6K
- NVCT 310.5K
- Earning Date
- ZVIA 11-06-2024
- NVCT 11-05-2024
- Dividend Yield
- ZVIA N/A
- NVCT N/A
- EPS Growth
- ZVIA N/A
- NVCT N/A
- EPS
- ZVIA N/A
- NVCT N/A
- Revenue
- ZVIA $153,385,000.00
- NVCT N/A
- Revenue This Year
- ZVIA N/A
- NVCT N/A
- Revenue Next Year
- ZVIA $7.64
- NVCT N/A
- P/E Ratio
- ZVIA N/A
- NVCT N/A
- Revenue Growth
- ZVIA N/A
- NVCT N/A
- 52 Week Low
- ZVIA $0.62
- NVCT $4.61
- 52 Week High
- ZVIA $2.48
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- ZVIA 70.35
- NVCT 37.34
- Support Level
- ZVIA $1.99
- NVCT $4.75
- Resistance Level
- ZVIA $2.39
- NVCT $5.49
- Average True Range (ATR)
- ZVIA 0.29
- NVCT 1.15
- MACD
- ZVIA 0.05
- NVCT -0.48
- Stochastic Oscillator
- ZVIA 80.90
- NVCT 6.81
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.